Moxonidine hydrochloride

Overview

Moxonidine (BDF5895) hydrochloride is an orally active imidazoline type 1 receptor (I 1 -R) agonist. Moxonidine hydrochloride activates imidazoline I 1 receptors and α 2 adrenoceptors , affecting oxidized low-density lipoprotein uptake. Moxonidine hydrochloride reduces atherosclerotic lesions and lowers blood pressure. Moxonidine hydrochloride can be used in the study of hypertension, heart failure, and atherosclerosis.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Depression | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Obesity | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Imidazoline Receptor | Products > Signaling Pathways > Adrenergic Receptor | Products > Signaling Pathways > LDLR

Product Information

• Catalog No.: HY-B0374A
• CAS No.: 75536-04-8
• Molecular Formula: C9H13Cl2N5O
• Molecular Weight: 278.14
• Purity: 99.83%
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Solubility: ≥ 2.5 mg/mL (8.99 mM); Clear solution
• Availability: In-stock

Source

Original product source